Abstract:Background: The worldwide spread of monkeypox (mpox) has witnessed a significant increase, particularly in nonendemic countries. Objective: We aimed to investigate the changing clinical symptoms associated with mpox from 1970 to 2023 and explore their interrelations. Methods: In this systematic review and meta-analysis, 3 electronic databases were searched for English peer-reviewed studies conducted from January 1970 to April 2023 that reported any symptoms among confirmed mpox cases. We categorized the mpox epidemics into 3 periods: 1970-2002 (period 1, within the African region), 2003-2021(period 2, epidemics outside Africa), and 2022-2023 (period 3, worldwide outbreak). Following PRISMA guidelines, a meta-analysis was performed to estimate the pooled prevalence for each symptom. The correlation among symptoms was analyzed and visualized using network analysis. Results: The meta-analysis included 61 studies that reported 21 symptoms in 720 patients from period 1, 39 symptoms in 1756 patients from period 2, and 37 symptoms in 12,277 patients from period 3. The most common symptom among patients from all 3 periods was rash (period 1: 92.6%, 95% CI 78.2%-100%; period 2: 100%, 95% CI 99.9%-100%; and period 3: 94.8%, 95% CI 90.9%-98.8%), followed by lymphadenopathy (period 1: 59.8%, 95% CI 50.3%-69.2%; period 2: 74.1%, 95% CI 64.2%-84.1%; and period 3: 61.1%, 95% CI 54.2%-68.1%). Fever (99%, 95% CI 97%-100%), enlarged lymph nodes (80.5%, 95% CI 75.4%-85.0%), and headache (69.1%, 95% CI 4%-100%) were the main symptoms in period 1, with a significant decrease in period 3: 37.9%, 31.2%, and 28.7%, respectively. Chills/rigors (73.3%, 95% CI 60.9%-85.7%), fatigue (68.2%, 95% CI 51.6%-84.8%), and dysphagia/swallowing difficulty (61.2%, 95% CI 10.5%-100%) emerged as primary new symptoms in period 2 and decreased significantly in period 3. Most other symptoms remained unchanged or decreased in period 3 compared to the former 2 periods. Nausea/vomiting had the highest degree of correlation (with 13 symptoms) and was highly positively correlated with lymphadenopathy (r=0.908) and conjunctivitis (r=0.900) in period 2. In contrast, rash and headache were 2 symptoms with the highest degree of correlation (with 21 and 21 symptoms, respectively) in period 3 and were highly positively correlated with fever (r=0.918 and 0.789, respectively). Conclusions: The manifestation of symptoms in patients with mpox has become more diverse, leading to an increase in their correlation. Although the prevalence of rash remains steady, other symptoms have decreased. It is necessary to surveil the evolving nature of mpox and the consequential changes in clinical characteristics. Epidemic countries may shift their focus on the potential association among symptoms and the high synergy risk. Trial Registration: PROSPERO Registration: CRD42023403282; http://tinyurl.com/yruuas5n

Association Between Public Attention and Monkeypox Epidemic: A Global Lag‐correlation Analysis

Trends in Online Search Activity and the Correlation with Daily New Cases of Monkeypox among 102 Countries or Territories

Real-time forecasting the trajectory of monkeypox outbreaks at the national and global levels, July-October 2022

Analysing monkeypox epidemic drivers: Policy simulation and multi-index modelling across 39 nations

Time series analysis and short-term forecasting of monkeypox outbreak trends in the 10 major affected countries

Monkeypox Virus and Current Trends: A Bibliometric Analysis of the Published Literature Based on VOSviewer

Association between Global Monkeypox Cases and Meteorological Factors

Unusual Global Outbreak of Monkeypox: What Should We Do?

Perceptions, Precautions, and Vaccine Acceptance Related to Monkeypox in the Public in China: A Cross-Sectional Survey

Frontiers of monkeypox research: An analysis from the top 100 most influential articles in the field

Monkeypox outbreaks in the context of the COVID-19 pandemic: Network and clustering analyses of global risks and modified SEIR prediction of epidemic trends

Bibliometric analysis of global research trends on monkeypox: are we ready to face this challenge?

High Global Health Security Index is a determinant of early detection and response to monkeypox: A cross-sectional study

2022 Multiple-country Monkeypox Outbreak and Its Importation Risk into China: an Assessment Based on the Risk Matrix Method.

Public sentiment on the global outbreak of monkeypox: an unsupervised machine learning analysis of 352,182 twitter posts

Monkeypox Knowledge Investigation and Knowledge Gap Analysis: An Online Cross-Sectional Survey in China

Climatic Determinants of Monkeypox Transmission: A Multi-National Analysis Using Generalized Count Mixed Models

Uncertain analysis of monkeypox outbreak in the Democratic Republic of the Congo

Monkeypox – A Danger Approaching Asia

Integrated Network Analysis of Symptom Clusters Across Monkeypox Epidemics From 1970 to 2023: Systematic Review and Meta-Analysis

Simulating the impact of optimized prevention and control measures on the transmission of monkeypox in the United States: A model‐based study